Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Oslo Bors  >  PCI Biotech Holding ASA    PCIB   NO0010405640

PCI BIOTECH HOLDING ASA

(PCIB)
  Report
Real-time Estimate Quote. Real-time Estimate CHI-X - 07/02 10:20:18 am
72.05 NOK   -5.94%
05/27PCI BIOTECH : Minutes from Annual General Meeting 2020
GL
05/06PCI BIOTECH : Notice of Annual General Meeting 2020
GL
05/06PCI BIOTECH : Q1 2020 Interim Report
PU
SummaryQuotesChartsNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news
Most relevant news about PCI BIOTECH HOLDING ASA
05/27PCI BIOTECH : Minutes from Annual General Meeting 2020
GL
05/06PCI BIOTECH : Notice of Annual General Meeting 2020
GL
05/06PCI BIOTECH : Q1 2020 Interim Report
PU
05/06PCI BIOTECH : First quarter 2020 results
GL
04/30PCI Biotech appoints Mr Ludovic Robin as Chief Business Officer
GL
04/28PCI BIOTECH : Invitation to Q1 2020 results presentation
PU
04/28PCI BIOTECH : Invitation to Q1 2020 results presentation
GL
04/22PCI Biotech Holding ASA publishes the Annual Report 2019
GL
03/31PCI Biotech appoints Dr Amir Snapir as Chief Medical Officer
GL
03/26PCI BIOTECH : US patent for the vaccine technology (fimaVacc) with a new importa..
GL
03/25PCI BIOTECH : Update on operational implications of the corona pandemic
GL
02/26PCI Biotech's fourth quarter and preliminary 2019 results
GL
02/19PCI BIOTECH : Invitation to fourth quarter and preliminary 2019 results presenta..
GL
01/21PCI BIOTECH : US patent granted for the vaccine technology (fimaVacc) in combina..
GL
2019PCI Biotech to present Phase I fimaVacc results at ESMO Immuno-Oncology 2019
GL
2019PCI BIOTECH : Third quarter 2019 results
GL
2019PCI BIOTECH : Expansion of preclinical research collaboration agreement with Ast..
GL
2019PCI Biotech to present at Jefferies 2019 London Healthcare Conference
GL
2019PCI BIOTECH : Invitation to third quarter 2019 results presentation
GL
2019PCI Biotech to present at BIO-Europe 2019
GL
2019PCI Biotech to present at World Vaccine Congress Europe
GL
2019PCI BIOTECH : Mandatory notification regarding trade of shares
GL
2019PCI BIOTECH : Capital increase registered and listing of new shares
GL
2019PCI BIOTECH : Exercise of employee share options, mandatory notification of trad..
GL
2019PCI BIOTECH : Mandatory notification regarding trade of shares
GL
2019PCI BIOTECH : Second quarter and first half 2019 results
GL
2019PCI BIOTECH : Invitation to second quarter and first half 2019 results presentat..
GL
2019PCI BIOTECH : Extension of preclinical research collaboration agreement with a t..
GL
2019PCI BIOTECH : to present at IPA World Congress
PU
2019PCI Biotech to present at IPA World Congress
GL
2019PCI BIOTECH : Employee share option scheme
GL
2019PCI BIOTECH : Minutes from Annual General Meeting 2019
PU
2019PCI BIOTECH : Minutes from Annual General Meeting 2019
GL
2019PCI BIOTECH : First patient enrolled in the fimaChem pivotal RELEASE study
PU
2019PCI BIOTECH : Notice of Annual General Meeting 2019
GL
2019PCI BIOTECH : First quarter 2019 results
GL
2019PCI BIOTECH : Successful clinical translation of the fimaVACC technology
PU
2019PCI BIOTECH : Successful clinical translation of the fimaVacc technology
GL
2019PCI BIOTECH : Invitation to first quarter 2019 result presentation
PU
2019PCI BIOTECH : Invitation to first quarter 2019 result presentation
GL
2019PCI BIOTECH : Annual Report 2018
GL
2019PCI BIOTECH : Final confirmation of successful safety read-out in the Phase I Ex..
PU
2019PCI BIOTECH : Final confirmation of successful safety read-out in the Phase I Ex..
GL
2018PCI BIOTECH : Preliminary confirmation of safety read-out from the fimaChem Phas..
PU
2018PCI BIOTECH HOLDING ASA : quaterly earnings release
2018PCI BIOTECH : Invitation to third quarter 2018 presentation
PU
2018PCI BIOTECH : Capital increase registered and listing of new shares
PU
2018PCI BIOTECH : Capital increase registered and listing of new shares
GL
2018PCI Biotech to present Phase I dose escalation results at ESMO
GL
2018PCI BIOTECH : Exercise of employee share options, mandatory noticifation of trad..
GL
2018Disclosure of large shareholding
GL
2018PCI BIOTECH : Capital increase registered and listing of new shares
PU
2018PCI BIOTECH : Capital increase registered and listing of new shares
GL
2018PCI BIOTECH : Final results of the rights issue
PU
2018PCI BIOTECH : Final results of the rights issue
GL
2018PCI BIOTECH : Last day of subscription period
PU
2018PCI BIOTECH : Last day of subscription period
GL
2018PCI BIOTECH : Last day of trading in subscription rights Monday 1 October 2018
PU
2018PCI BIOTECH : Last day of trading in subscription rights Monday 01 October 2018
GL
2018Disclosure of large shareholdings
GL
2018PCI BIOTECH : Mandatory notification regarding exercise and trade of subscriptio..
PU
2018PCI BIOTECH : Commencement of subscription period
PU
2018PCI BIOTECH : Mandatory notification regarding exercise and trade of subscriptio..
GL
2018PCI BIOTECH : Prospectus approved
PU
2018PCI BIOTECH : Prospectus approved
GL
2018PCI BIOTECH HOLDING ASA : RIGHTS ISSUE: 0.48 new shares @ 30 NOK for 1 existing ..
FA
2018PCI BIOTECH : Rights issue approved by the extraordinary general meeting
PU
2018PCI BIOTECH : Rights issue approved by the extraordinary general meeting
GL
2018PCI BIOTECH : Second quarter and first half-year 2018 results
PU
2018PCI BIOTECH : Second quarter and first half-year 2018 results
GL
2018PCI BIOTECH HOLDING ASA : half-yearly earnings release
2018Key information relating to the preferential rights issue to be carried out b..
GL
2018PCI BIOTECH : Notice of Extraordinary General Meeting
GL
2018PCI BIOTECH : Invitation to first half year 2018 presentation
PU
2018PCI BIOTECH : Invitation to first half year 2018 presentation
GL
1  2Next
Upcoming event on PCI BIOTECH HOLDING ASA